Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W van Oosten

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 28, 2013
What went wrong? The flawed concept of cerebrospinal venous insufficiencyJosé M Valdueza, Florian Doepp, Stephan J Schreiber, et al.
The Journal of Clinical Investigation|May 1, 1997
Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humansM H Rep, B W van Oosten, M T Roos, et al.
Lancet (London, England)|October 7, 1995
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosisJ B Crusius, A S Peña, B W Van Oosten, et al.
Annals of Neurology|July 28, 2010
Natalizumab drug holiday in multiple sclerosis: poorly toleratedJoep Killestein, Anke Vennegoor, Eva M Strijbis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosisB W van Oosten, M Lai, F Barkhof, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2019
Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidenceAxel Petzold, Tasanee Braithwaite, Bob W van Oosten, et al.
Neurology|February 9, 2011
Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MSA Vennegoor, M P Wattjes, E T L van Munster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Natalizumab concentrations during pregnancy in three patients with multiple sclerosisAlyssa A Toorop, Theo Rispens, Eva Mm Strijbis, et al.
Neuroimage|October 18, 2005
Multiple sclerosis patients show a highly significant decrease in alpha band interhemispheric synchronization measured using MEGKeith S Cover, Hugo Vrenken, Jeroen J G Geurts, et al.
Neurology|December 1, 1996
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosisL Truyen, J H van Waesberghe, M A van Walderveen, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 28, 2013
What went wrong? The flawed concept of cerebrospinal venous insufficiencyJosé M Valdueza, Florian Doepp, Stephan J Schreiber, et al.
The Journal of Clinical Investigation|May 1, 1997
Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humansM H Rep, B W van Oosten, M T Roos, et al.
Lancet (London, England)|October 7, 1995
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosisJ B Crusius, A S Peña, B W Van Oosten, et al.
Annals of Neurology|July 28, 2010
Natalizumab drug holiday in multiple sclerosis: poorly toleratedJoep Killestein, Anke Vennegoor, Eva M Strijbis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosisB W van Oosten, M Lai, F Barkhof, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2019
Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidenceAxel Petzold, Tasanee Braithwaite, Bob W van Oosten, et al.
Neurology|February 9, 2011
Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MSA Vennegoor, M P Wattjes, E T L van Munster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Natalizumab concentrations during pregnancy in three patients with multiple sclerosisAlyssa A Toorop, Theo Rispens, Eva Mm Strijbis, et al.
Neuroimage|October 18, 2005
Multiple sclerosis patients show a highly significant decrease in alpha band interhemispheric synchronization measured using MEGKeith S Cover, Hugo Vrenken, Jeroen J G Geurts, et al.
Neurology|December 1, 1996
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosisL Truyen, J H van Waesberghe, M A van Walderveen, et al.
Pageof 8